INTRALINE® TRIPLE TR2650 - 26G 50mm/70mm

Key features of the INTRALINE® TRIPLE TR2650 include:

• Needle Size: Available in 26G, allowing precise injections.
• Needle Length: Available in two options—50mm and 70mm, for different treatment depths.
• Hyaluronic Acid: Utilizes BDDE-crosslinked hyaluronic acid, ensuring enhanced skin elasticity and volume.
• Lidocaine Inclusion: Contains lidocaine (3 mg/ml) to reduce discomfort during the injection process.
• Duration of Results: Typically, the effects last between 6-12 months, depending on the treated area and patient-specific factors.
• Safety: CE-approved, ensuring compliance with international medical safety standards.

The INTRALINE® TRIPLE TR2650 is suitable for:

• Treating deep wrinkles in areas like the nasolabial folds, marionette lines, cheeks, and jawline.
• It is ideal for restoring volume and contouring the face, particularly in patients with moderate to severe facial volume loss.
  Contraindications include:
• Allergy to hyaluronic acid or any other ingredient in the filler.
• Pregnancy and breastfeeding, as safety during these conditions has not been established.
• Severe skin infections or inflammation in the target area.
  Side effects may include:
• Redness, swelling, or bruising at the injection site, which typically resolves within a few days.
• Skin sensitivity and tenderness during the initial post-treatment period. Rarely, infection or granuloma formation may occur.

The INTRALINE® TRIPLE TR2650 dermal filler is formulated using high-quality, biofermented hyaluronic acid. It is produced without animal-derived ingredients, making it suitable for those with sensitivities to animal products.

• Hyaluronic Acid: Provides deep hydration and helps restore skin volume and elasticity.
• Lidocaine: A local anesthetic that reduces pain during the procedure, improving patient comfort.
• Packaging: Each syringe contains 1.1 ml of product. The packaging includes 2 needles of size 27G or 30G for precise injection.
  The product is carefully manufactured in Sweden, ensuring high quality and consistency.

The INTRALINE® TRIPLE TR2650 should be injected into the dermis or subcutaneous tissue depending on the treatment area and desired effect. Here are the recommended steps for use:

1. Prepare the skin: Cleanse and disinfect the area to be treated.
2. Mark the injection points: Based on the patient’s treatment plan, mark the areas for injection.
3. Inject the filler: Use the 26G needle to inject the product at the appropriate depth (typically the dermis or subcutaneous layer) while ensuring even distribution for a smooth and natural result.
4. Post-procedure care: After the procedure, avoid touching the treated area. Apply a soothing cream if necessary. It is important to avoid extreme heat, sun exposure, or strenuous activity for at least 24 hours after treatment.
   Follow-up treatments can be scheduled as needed based on patient results, typically every 6-12 months for optimal maintenance of the results.